-
1دورية أكاديمية
المؤلفون: Chen, Huei-JenAff1, Aff2, Cheng, Yi-An, Chen, Yu-Tung, Li, Chia-Ching, Huang, Bo-ChengAff1, Aff3, Hong, Shih-Ting, Chen, I.-JuAff3, Aff12, Ho, Kai-Wen, Chen, Chiao-YunAff3, Aff5, Aff6, Chen, Fang-MingAff7, Aff8, Aff9, Wang, Jaw-Yuan, Roffler, Steve R.Aff2, Aff10, Cheng, Tian-LuAff1, Aff3, Aff4, IDs12645023002306_cor13, Wu, Dung-HoAff11, IDs12645023002306_cor14
المصدر: Cancer Nanotechnology: Basic,Translational and Clinical Research. 14(1)
-
2دورية أكاديمية
المؤلفون: Huei-Jen Chen, Yi-An Cheng, Yu-Tung Chen, Chia-Ching Li, Bo-Cheng Huang, Shih-Ting Hong, I.-Ju Chen, Kai-Wen Ho, Chiao-Yun Chen, Fang-Ming Chen, Jaw-Yuan Wang, Steve R. Roffler, Tian-Lu Cheng, Dung-Ho Wu
المصدر: Cancer Nanotechnology, Vol 14, Iss 1, Pp 1-17 (2023)
مصطلحات موضوعية: PEGylated nanoparticles (PEG-NPs), Enhanced permeability and retention effect (EPR effect), Anti-PEG bispecific antibody (BsAb, mPEG × CD20), CD20-armed liposomes, αCD20/PLD, Hematologic malignancies, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource